National Analysts Worldwide Launches New ‘Day in the Life Sciences’ Blog

Blog will provide leaders in pharmaceutical, healthcare and biotechnology with insight into the minds of their customers and stakeholders

PHILADELPHIA--(BUSINESS WIRE)-- Today NationalAnalysts Worldwide opened a window into the hearts and minds of healthcare customers and providers with the introduction of a new blog at http://blog.nationalanalysts.com. The blog is another way the strategic marketing research consultancy will help leaders in the life sciences and pharmaceutical industry reach their target audience for products and therapies by gaining a deeper understanding of their customers.

“The new National Analysts Worldwide blog will draw on the unique insights we develop as an organization whose mission is to understand how all participants in the healthcare system—physicians, patients, payers—view the world and see each other,” says Susan Schwartz McDonald, Ph.D., President and CEO of National Analysts Worldwide. “We’ve been studying the marketplace for 100 years and we’ve really trained our eye on healthcare in a specialized way for the past 40—longer than any other company in our field. That longtime focus has given us a unique angle of view on every customer and every stakeholder in the healthcare environment because we shuttle back and forth between them all like ambassadors. We think there’s no better place than a blog to share those insights with the industry at large.”

The firm’s bloggers will be sharing that perspective in a voice that speaks to developers and marketers of new therapies, healthcare experts, and even, on occasion, clinicians.

“At National Analysts Worldwide, we are as fluent in the language of health science and government regulation as we are in the language of marketing and market research,” notes Debra A. Kossman, Ph.D., Senior Vice President of National Analysts Worldwide and lead healthcare blogger. “That equips us to talk about everything from the challenges of developing new therapies to the hurdles associated with persuading physicians to prescribe them and insurance companies to reimburse them. We’re uniquely equipped to explain to marketers and to physicians why patients may resist discoveries that are meant to save their lives.”

Debbie will soon be joined by other National Analysts Worldwide experts and guests in covering diverse and provocative topics such as the concept of “brand” in healthcare, the impact of direct-to-consumer advertising, the challenge of forecasting demand for innovative therapies, and the impact of “patient democracy” on everything from what physicians prescribe to how patients will choose healthcare coverage.

“We’re a firm that helped bring to market drugs that literally defined the age of modern medicine,” adds McDonald. “We have played a key role in commercializing some of those great blockbusters of the 20^th century, including cholesterol-lowering drugs, antidepressants, drugs to treat osteoporosis, and drugs to treat acid reflux.”

Kossman is already sharing her 25 years of experience leading a full range of marketing research assignments for pharmaceutical and biotechnology companies in posts such as:

• Emerging Notions of “Valued-Based Health Care” Are Raising the Bar and Extending Forecasting Horizons for New Drug Therapies—Kossman takes a look at what constitutes value in healthcare and how this impacts the length of clinical trials and performance testing of new products and therapies, and the subsequent pricing and positioning. From there, she examines what will be essential for competitive advantage in the industry as providers look for ways to guide therapy choices and outcome assessment.
• Healthcare Cost Savings from Expanded Access to Preventive Medicine Could be Dead on Arrival—Kossman examines the conflict between treatment and prevention in America’s healthcare system, and the unrealistic hope being placed on incentives as a way to promote preventive medicine and lower costs. According to Kossman’s research, the impediments to prevention medicine and health maintenance might lie less with our healthcare system than with the psychological makeup of the patients it's meant to serve.

The National Analysts Worldwide life sciences marketing blog is located at http://blog.nationalanalysts.com. Visit the blog daily or subscribe to the blog's RSS feed for the latest updates. Readers are encouraged to comment on the blog. For more information about National Analysts Worldwide and its 100-year history of marketing research expertise, visit www.NationalAnalysts.com.

About National Analysts Worldwide

National Analysts Worldwide is a leading research-based consultancy that serves both Fortune 100 companies and innovative start-ups by integrating expertise in research methodology with deep sector experience in industries like Healthcare, Consumer Products, Information Technology, Communications, and Financial Services. Drawing on a century of industry leadership, the firm integrates market research with business consulting to address marketing challenges from opportunity assessment and launch strategy to brand health and lifecycle management.

National Analysts Worldwide is known for expertise in modeling, market segmentation, demand forecasting, and research that drives improvements in brand strategy, positioning, pricing, product development, and the customer experience. http://www.nationalanalysts.com/

Press Contact:
Gregory FCALauren Rumsey, Account Executive, 610-228-2132
[email protected]
or
Company Contact:
National Analysts WorldwidePatricia Green, Special Projects Coordinator, 215-496-6870
[email protected]

Source: National Analysts Worldwide